AI-generated summary
The authors studied whether a peptide serum used alongside 1540 nm non-ablative fractional laser treatment could help striae distensae, or stretch marks, in 10 patients. They report that all patients felt subjectively improved, and that adding the serum was associated with greater objective improvement, less post-inflammatory hyperpigmentation and higher patient satisfaction.
- Participants
- 10
- Who or what was studied
- Patients with striae distensae (stretch marks); the abstract does not describe age, sex or other characteristics.
- Wavelengths
- 1540 nm
- Limits stated in the abstract
- The abstract describes a pilot study of only 10 patients and does not mention a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1540 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Pilot study, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.